ICON PLC (ICLR) Stock Forecast

ICON plc (ICLR) Fell due to Persistent Volatility in the Clinical Development Market

on MSN ago, source: Insider Monkey on MSN.com

Baron Funds, an investment management company, released its “Baron Small Cap Fund” second-quarter 2025 investor letter. A ...

ICON suspends COVID vaccine study after BARDA notice to sponsor

on MSN ago, source: Seeking Alpha

ICON plc ( NASDAQ: ICLR) has announced the suspension of its COVID vaccine study following a stop work notice from BARDA. The ...

ICON plc Halts COVID Vaccine Study Following BARDA Notice

5d ago, source: None

Icon ( ($ICLR) ) just unveiled an update. On August 12, 2025, ICON plc announced that a large-scale next-generation COVID vaccine study, which had ...

Icon PLC (ICLR) Up 2.3% Since Last Earnings Report: Can It Continue?

12mon ago, source: Yahoo Finance

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have added about 2.3% in that time frame, underperforming the S&P 500. Will the recent positive trend continue ...

ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials ...

1mon ago, source: Finanznachrichten

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 ...

Icon PLC (ICLR) Upgraded to Buy: Here's What You Should Know

1y ago, source: Yahoo Finance

Icon PLC (ICLR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ICON to partner with US government agency to test COVID vaccine ...

1y ago, source: Reuters

Contract research firm ICON Plc said on Wednesday it is partnering with the U.S. government for a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates.

ICON PLC: PRA Health Deal A No Brainer, But It's Marginal (NASDAQ:ICLR)

4y ago, source: Seeking Alpha

ICON PLC is a Contract Research Organization (CRO) that generated revenues of $2.8bn in FY20, and whose share price is +173% over a five-year period.

ICON Plc Announces Completion of $40 Million Share Buyback and a ...

10y ago, source: FierceBiotech

DUBLIN-- ICON plc, (Nasdaq: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a ...

Icon PLC (ICLR) Upgraded to Buy: Here's What You Should Know

1y ago, source: Nasdaq

Investors might want to bet on Icon PLC (ICLR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
Absci Corp	ABSI	Predict	350.79	-4.73	1.76
bioAffinity Technologies, Inc.	BIAF	Predict	6.63	-1.10	3.65
bioAffinity Technologies, Inc.	BIAFW	Predict	9.35	None	3.00
Cannabis Bioscience International Holdings, Inc.	CBIH	Predict	5.47	None	None
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	CRL	Predict	7956.22	19.33	2.37
FOXO TECHNOLOGIES INC.	FOXO	Predict	0.00	None	0.00
ICON PLC	ICLR	Predict	14108.68	14.37	1.48
INCYTE CORP	INCY	Predict	17255.88	19.82	4.14
IQVIA HOLDINGS INC.	IQV	Predict	33544.46	27.12	5.81
iSpecimen Inc.	ISPC	Predict	2.68	-2.22	1.61
LUNA INNOVATIONS INC	LUNA	Predict	61.44	45.25	0.65
Medpace Holdings, Inc.	MEDP	Predict	13811.05	33.02	80.13
MAXCYTE, INC.	MXCT	Predict	144.97	-10.56	0.76
Inotiv, Inc.	NOTV	Predict	64.93	-1.30	0.45
NATIONAL RESEARCH CORP	NRC	Predict	353.72	19.73	16.59
OmniAb, Inc.	OABI	Predict	246.63	-6.45	0.94
OmniAb, Inc.	OABIW	Predict	62.93	None	0.22
OneMedNet Corp	ONMD	Predict	17.50	None	-1.06
OneMedNet Corp	ONMDW	Predict	0.71	None	-0.05